{"ticker": {"uuid": "8d8f09fb-b1c6-4ba2-af92-ef16f23997e2", "symbol": "FYB", "name": "Formycon AG", "exchange": "VIE", "country": "AT", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Formycon and MS Pharma sign exclusive commercialization partnership for Keytruda\u00ae biosimilar candidate FYB206 for the MENA Region", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgJBVV95cUxPTXhHQUNtMWV5YUdFZ2FCNXNFdExVQVNZTWp6V01ET0tBbmV0RGtROVlIVmtDT2NjWHQ3WEdCV09XVUtVQ1NMdnIxWno2bW50bWg2TEo5eTBqelYwcl8wNE9BUDZvVE5FM0NPU3FfaEtGTkJkSGkxZGNwMV9iSGV5UmlnYTlhTS1uSTA2YlZQOVVPcjJOZzBEdENDTEUyTWlaUlN5VGltcHJfbXdEM19FaDlmMXdFd2V5TGVDUlBwNE5GZFVJUE9XRTZ4Ym11emZxWlRJZXhhRU9lb3hhcG5WUUNKS0JSTVRRYmZEQVNwRGlxZGpFeHhuU3h2dXlick1EbVYycDd4ZnRMZ1ZZb0g4YlUzb0VfZw?oc=5", "source_name": "PR Newswire", "published_at": "2025-12-04T08:00:00+00:00", "published_display": "04 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Formycon Ag Stock Price Forecast. Should You Buy FYB.DE?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiS0FVX3lxTFBsTFVhclBlbGtVQ1c5ZzVad09JakxsYlRXY0tMemtfNHJ2cm9QdURlRnBLMW94bkNOdGwxWFIydkRPcUJ1TGdkR0JDVQ?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-22T15:47:40+00:00", "published_display": "22 Dec 2020 15:47", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Formycon AG: Target Price Consensus and Analysts Recommendations | FYB | DE000A1EWVY8", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE45eE53VFF0OVgxZFc2Tk9LVm02cEVxUHhrdWhUek9sb0Z0dUhDc3NoeHJvRV9LeDI2YVpxZHhVZVVaZnE2MTRSazFNUFFMQW9NcmdSaGE3elMyUnU5U083UnpKMkx0MFd6elJKbGVwNVBvOUNlZlZkQzV3dTFyQQ?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-19T17:22:50+00:00", "published_display": "19 Aug 2020 17:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Formycon and MS Pharma sign exclusive commercialization partnership for Keytruda\u00ae biosimilar candidate FYB206 for the MENA Region", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgJBVV95cUxPTXhHQUNtMWV5YUdFZ2FCNXNFdExVQVNZTWp6V01ET0tBbmV0RGtROVlIVmtDT2NjWHQ3WEdCV09XVUtVQ1NMdnIxWno2bW50bWg2TEo5eTBqelYwcl8wNE9BUDZvVE5FM0NPU3FfaEtGTkJkSGkxZGNwMV9iSGV5UmlnYTlhTS1uSTA2YlZQOVVPcjJOZzBEdENDTEUyTWlaUlN5VGltcHJfbXdEM19FaDlmMXdFd2V5TGVDUlBwNE5GZFVJUE9XRTZ4Ym11emZxWlRJZXhhRU9lb3hhcG5WUUNKS0JSTVRRYmZEQVNwRGlxZGpFeHhuU3h2dXlick1EbVYycDd4ZnRMZ1ZZb0g4YlUzb0VfZw?oc=5", "source_name": "PR Newswire", "published_at": "2025-12-04T08:00:00+00:00", "published_display": "04 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Formycon Ag Stock Price Forecast. Should You Buy FYB.DE?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiS0FVX3lxTFBsTFVhclBlbGtVQ1c5ZzVad09JakxsYlRXY0tMemtfNHJ2cm9QdURlRnBLMW94bkNOdGwxWFIydkRPcUJ1TGdkR0JDVQ?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-22T15:47:40+00:00", "published_display": "22 Dec 2020 15:47", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Formycon AG: Target Price Consensus and Analysts Recommendations | FYB | DE000A1EWVY8", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE45eE53VFF0OVgxZFc2Tk9LVm02cEVxUHhrdWhUek9sb0Z0dUhDc3NoeHJvRV9LeDI2YVpxZHhVZVVaZnE2MTRSazFNUFFMQW9NcmdSaGE3elMyUnU5U083UnpKMkx0MFd6elJKbGVwNVBvOUNlZlZkQzV3dTFyQQ?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-19T17:22:50+00:00", "published_display": "19 Aug 2020 17:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 56, "total_relevant": 3, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 2, "score": 55, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "deals", "primary_label": "Deals and strategy", "confidence": 54, "events": [{"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 18.84, "latest_week": "2026-07-10", "one_week_move": -2.2, "four_week_move": -9.6, "twelve_week_move": -3.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.0, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": -3.6, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 54.7703, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.2% over one week, -9.6% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 55, "badges": [], "opportunities": [], "risks": [], "event_label": "Deals and strategy", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "PR Newswire", "count": 1}, {"label": "StockInvest.us", "count": 1}, {"label": "marketscreener.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Deals and strategy", "count": 1}, {"label": "Guidance", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Deals and strategy", "tone": "neutral", "text": "54/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.2% over one week, -9.6% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Formycon and MS Pharma sign exclusive commercialization partnership for Keytruda\u00ae biosimilar candidate FYB206 for the MENA Region"}], "updated_at": "2026-07-18T02:09:44.621950+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}